Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Urologic Neoplasms, Endometrial Neoplasms

NCT05455424 2025-05-15

NERO

Phase 2 Completed

88 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Recurrence

NCT03207347 2023-09-15

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Phase 2 Completed

37 enrolled 15 charts

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Mesothelioma, Cholangiocarcinoma

NCT04940637 2023-05-12

UNITO-001

Phase 2 Unknown

70 enrolled

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT03654833 2023-03-14

MiST

Phase 2 Unknown

186 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05162196 2022-05-02

The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer

Phase 2 Unknown

57 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT03221400 2022-02-17

PEN-866 in Patients With Advanced Solid Malignancies

Phase 1/2 Unknown

340 enrolled

GastrointestinalThoracic

Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT03891615 2020-12-16

Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer

Phase 1 Unknown

30 enrolled

Thoracic

Lung Neoplasms